logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
U

Ugo De Giorgi

university oncology unit

79H指数
980论文数
3.0W被引数
收录论文 346
发表时间
logo
Baseline serum carcinoembryonic antigen (CEA) is an independent prognostic biomarker for metastatic castration-resistant prostate cancer (mCRPC) patients receiving 177Lu-PSMA therapy基线血清癌胚抗原（CEA）是接受177Lu-PSMA治疗的转移性去势抵抗性前列腺癌（mCRPC）患者的独立预后生物标志物
errEuropean Journal of Nuclear Medicine and Molecular Imaging
IF7.6
err2026-09-11
err0
errOAAI
errEmilio Francesco Giunta; Irene Marini; Ilaria Grassi; Silvia Nicolini; Flavia Foca; Monica Celli; Paola Caroli; Anna Sarnelli; Nicole Brighi; Giuseppe Schepisi; Manuela Monti; Ugo De Giorgi; Cristian Lolli; Maddalena Sansovini
err分享
err收藏
Prognostic impact of variants of uncertain significance (VUS) in BRCA genes and homologous recombination repair (HRR) genes in prostate cancer: a real-world multicenter studyBRCA基因和同源重组修复（HRR）基因中意义不明的变异（VUS）对前列腺癌预后的影响：一项真实世界多中心研究
errBMC Medicine
IF8.3
err2026-08-04
err0
errOAAI
errMarianna Garofoli; Maria Iole Natalicchio; Giuseppina Bruno; Aldo Rosano; Brigida Anna Maiorano; Sabrina Rossetti; Sarah Scagliarini; Lorena Incorvaia; Luigi Formisano; Ilaria Toma; Guido Giordano; Giovanna Pecoraro; Francesco Grillone; Laura Palumbo; Marco Pisino; Marta Palladino; Concetta Rita Di Pippo; Valeria Bafunno; Nicole Brighi; Chiara Casadei; Cristian Lolli; Maria Concetta Cursano; Vincenzo Emanuele Chiuri; Pasquale Rescigno; Emiliano Tamburini; Francesca Sanguedolce; Fabio Calabrò; Ugo De Giorgi; Matteo Landriscina; Vincenza Conteduca
err分享
err收藏
DURATION OF TREATMENT SUSPENSION AMONG ALL RANDOMIZED PATIENTS IN EMBARKEMBARK研究中所有随机化患者治疗中断的持续时间
errJournal of Urology
IF6.8
err2026-05-01
err0
PREAI
errShore, Neal D.; Sieber, Paul R.; De Giorgi, Ugo; Danila, Daniel C.; Dunshee, Curtis J.; Lallas, Costas D.; Pliskin, Marc J.; Morgans, Alicia K.; Tang, Yiyun; Rosales, Matt; Wang, Fong; Kennedy, Dana; Freedland, Stephen J.
err分享
err收藏
Treatment of High-Risk Biochemically Recurrent Prostate Cancer With Enzalutamide in Combination With Leuprolide: Secondary End Points From the EMBARK Trial使用恩扎卢胺联合醋酸亮丙瑞林治疗高风险生化复发的前列腺癌：EMBARK试验的次要终点
errJournal of Urology
IF6.8
err2026-05-01
err6
PREAI
errShore, Neal D.; Gleave, Martin; De Giorgi, Ugo; Rannikko, Antti; Pieczonka, Christopher M.; Sridharan, Swetha; Brasso, Klaus; Woo, Henry H.; Gomez Caamano, Antonio; Saranchuk, Jeff W.; Nordquist, Luke T.; Ferreira, Ubirajara; Tang, Yiyun; Rosbrook, Brad; Haas, Gabriel P.; Rosales, Matt; Zohren, Fabian; Tarazi, Jamal; Freedland, Stephen J.
err分享
err收藏
The Prognostic Power of miR-21 in Breast Cancer: A Systematic Review and Meta-AnalysismiR-21在乳腺癌中的预后价值：一项系统评价和Meta分析
errInternational Journal of Molecular Sciences
IF4.9
err2026-03-03
err0
errOAAI
errLuana Conte; Maria Rosaria Tumolo; Giorgio De Nunzio; Ugo De Giorgi; Roberto Guarino; Donato Cascio; Federico Cucci
err分享
err收藏
Strategies to Mitigate Breast-related Adverse Events in Patients with High-risk Biochemically Recurrent Prostate Cancer Receiving Enzalutamide Monotherapy: Perspectives and Challenges
errEuropean Urology Focus
IF5.6
err2025-12-18
err0
errOAAI
errNeal D. Shore; Stephen J. Freedland; Lisa G. Horvath; Joe M. O’Sullivan; Ugo De Giorgi; Edward C. Ray; Ashley E. Ross; Yiyun Tang; David Russell; Kenneth K. Iwata; Matt Rosales; Arijit Ganguli; Bertrand Tombal
err分享
err收藏
Efficacy, toxicity, and clinical outcomes of 177Lu-PSMA-617 radioligand therapy at 5.5 GBq per cycle in patients with advanced castration-resistant prostate cancer: a prospective, single arm, phase II study177Lu-PSMA-617放射性配体疗法的疗效、毒性和临床结局：一项前瞻性、单臂、II期研究，研究对象为每周期接受5.5 GBq剂量的晚期去势抵抗性前列腺癌患者
errEuropean Journal of Nuclear Medicine and Molecular Imaging
IF7.6
err2025-11-27
err0
errOAAI
errIrene Marini; Emilio Francesco Giunta; Silvia Nicolini; Ilaria Grassi; Flavia Foca; Anna Sarnelli; Valentina Di Iorio; Lilla Vizza; Erika Giani; Monica Celli; Manuela Monti; Stefano Severi; Ugo De Giorgi; Francesca Borgia; Giovanni Paganelli; Federica Matteucci; Maddalena Sansovini
err分享
err收藏
Corrigendum to Talazoparib plus enzalutamide in metastatic castration-resistant prostate cancer: Safety analyses from the randomized, placebo-controlled, phase III TALAPRO-2 study [European Journal of Cancer Volume 213, December 2024, 115078]勘误：Talazoparib 联合 enzalutamide 治疗 metastatic castration-resistant prostate cancer 的安全性分析，来自随机、安慰剂对照、III 期 TALAPRO-2 研究的结果 [European Journal of Cancer Volume 213, December 2024, 115078]
errEuropean Journal of Cancer
IF7.1
err2025-11-13
err0
PREAI
errArun A. Azad; Karim Fizazi; Nobuaki Matsubara; Fred Saad; Ugo De Giorgi; Jae Young Joung; Peter C.C. Fong; Robert J. Jones; Stefanie Zschäbitz; Jan Oldenburg; Neal D. Shore; Curtis Dunshee; Joan Carles; Andre P. Fay; Xun Lin; Liza DeAnnuntis; Nicola Di Santo; Michael A. Zielinski; Neeraj Agarwal
err分享
err收藏
Real-life Use of Cabozantinib in Front-line therapy for Metastatic Renal Cell Carcinoma: The CabFRONT Study (Meet-URO 24)卡博替尼在转移性肾细胞癌一线治疗中的真实世界应用：CabFRONT研究（Meet-URO 24）
errEuropean Urology Open Science
IF4.5
err2025-10-13
err0
errOAAI
errMarco Stellato; Pierangela Sepe; Enrico Bronte; Vincenza Conteduca; Maria Cossu Rocca; Ugo De Giorgi; Marilena Di Napoli; Luca Galli; Lorena Incorvaia; Luca Lalli; Brigida Anna Maiorano; Marco Maruzzo; Alessia Mennitto; Giandomenico Roviello; Matteo Santoni; Mariella Sorarù; Elisa Zanardi; Paolo Zucali; Giuseppe Procopio; Elena Verzoni
err分享
err收藏
Genomically matched therapy in advanced solid tumors: the randomized phase 2 ROME trial基因组匹配疗法在晚期实体瘤中的应用：随机II期ROME试验
errNature Medicine
IF50
err2025-09-29
err0
errOAAI
errPaolo Marchetti; Giuseppe Curigliano; Mauro Biffoni; Sara Lonardi; Simone Scagnoli; Lorenzo Fornaro; Valentina Guarneri; Ugo De Giorgi; Paolo Antonio Ascierto; Giovanni Blandino; Giulia D’Amati; Massimo Aglietta; Chiara Cremolini; Pierfranco Conte; Edoardo Crimini; Maurizio Ceracchi; Simona Pisegna; Sofia Verkhovskaia; Roberto Bordonaro; Sergio Bracarda; Giovanni Butturini; Lucia Del Mastro; Andrea DeCensi; Agnese Fabbri; Elisabetta Fenocchio; Stefania Gori; Giulio Metro; Annamaria Pessino; Daniele Pozzessere; Fabio Puglisi; Stefano Tamberi; Alberto Zambelli; Donatella Marino; Ettore Capoluongo; Federico Cappuzzo; Bruna Cerbelli; Giuseppe Giannini; Umberto Malapelle; Federica Mazzuca; Marianna Nuti; Giancarlo Pruneri; Maurizio Simmaco; Lidia Strigari; Giuseppe Tonini; Nello Martini; Andrea Botticelli
err分享
err收藏
Impact of treatment suspension on health-related quality of life in the EMBARK trial: a post hoc analysis治疗暂停对EMBARK试验中健康相关生活质量的影响：一项事后分析
erreClinicalMedicine
IF10
err2025-08-14
err0
PREAI
errStephen J. Freedland; Ugo De Giorgi; Antti Rannikko; Fred Saad; Miguel Ramirez-Backhaus; Anchen F. Nasr; Jasmina I. Ivanova; Arijit Ganguli; Pavol Kral; Arlene L. Reisman; Neal D. Shore
err分享
err收藏
Effectiveness of nivolumab-based immunotherapy and prognostic stratification by the Meet-URO score in real-world older patients with metastatic renal cell carcinoma基于纳武利尤单抗的免疫疗法在真实世界老年转移性肾细胞癌患者中的疗效及通过Meet-URO评分进行的预后分层
errJournal of Geriatric Oncology
IF2.7
err2025-08-12
err0
PREAI
errVeronica Murianni; Marina Campione; Malvina Cremante; Umberto Basso; Lucia Fratino; Sebastiano Buti; Sergio Bracarda; Marco Maruzzo; Ugo De Giorgi; Giampaolo Tortora; Silvia Chiellino; Lorenzo Antonuzzo; Luca Galli; Paolo Andrea Zucali; Mimma Rizzo; Alessio Signori; Diana Giannarelli; Giuseppe Procopio; Pasquale Rescigno; Giuseppe Fornarini; Sara Elena Rebuzzi; Giuseppe Luigi Banna
err分享
err收藏
Nivolumab plus cabozantinib in metastatic renal cell carcinoma: real-world evidence from the international ARON-1 study纳武利尤单抗联合卡博替尼治疗转移性肾细胞癌：国际ARON-1研究的真实世界证据
errFrontiers in Oncology
IF3.3
err2025-07-27
err0
errOAAI
errMaria T. Bourlon†; Luca Galli†; Enrique Grande; Se Hoon Park; Bohuslav Melichar; Timothy J. Schieber; Maria José Juan-Fita; Yüksel Ürün; Javier Molina-Cerrillo; Teresa Alonso-Gordoa; Ugo De Giorgi; Jakub Kucharz; Esther Pérez Calabuig; Vincenza Conteduca; Tarek Taha; Pasquale Rescigno; Hussam Abu-Sini; Gian Paolo Spinelli; Ray Manneh Kopp; Alessia Salfi; Dipen Bhuva; Paola Valdez-Sandoval; Sofia Mendez-Bribiesca; Ondrej Fiala; Sebastiano Buti; Fernando Sabino Marques Monteiro; Aristotelis Bamias; Marwan Ghosn; Francesco Massari; Jawaher Ansari‡; Matteo Santoni‡
err分享
err收藏
Talazoparib plus enzalutamide in men with metastatic castration-resistant prostate cancer: final overall survival results from the randomised, placebo-controlled, phase 3 TALAPRO-2 trialTalazoparib 联合 enzalutamide 治疗 metastatic castration-resistant prostate cancer 男性患者的最终总生存结果：来自随机、安慰剂对照、III期 TALAPRO-2 试验的数据
errlancet
IF0
err2025-07-16
err0
PREAI
errNeeraj Agarwal; Arun A Azad; Joan Carles; André P Fay; Nobuaki Matsubara; Cezary Szczylik; Ugo De Giorgi; Jae Young Joung; Peter C C Fong; Eric Voog; Robert J Jones; Neal D Shore; Fred Saad; Curtis Dunshee; Stefanie Zschäbitz; Jan Oldenburg; Xun Lin; Cynthia G Healy; Matko Kalac; Dana Kennedy; Karim Fizazi
err分享
err收藏
Talazoparib plus enzalutamide in men with HRR-deficient metastatic castration-resistant prostate cancer: final overall survival results from the randomised, placebo-controlled, phase 3 TALAPRO-2 trialTalazoparib 联合 enzalutamide 治疗 HRR 缺陷型转移性去势抵抗性前列腺癌的男性患者：来自随机、安慰剂对照的 III 期 TALAPRO-2 试验的最终总生存结果
errlancet
IF0
err2025-07-16
err0
PREAI
errKarim Fizazi; Arun A Azad; Nobuaki Matsubara; Joan Carles; André P Fay; Ugo De Giorgi; Jae Young Joung; Peter C C Fong; Eric Voog; Robert J Jones; Neal D Shore; Curtis Dunshee; Stefanie Zschäbitz; Jan Oldenburg; Dingwei Ye; Xun Lin; Matko Kalac; A Douglas Laird; Dana Kennedy; Neeraj Agarwal
err分享
err收藏
Enfortumab vedotin plus pembrolizumab versus chemotherapy in patients with previously untreated locally advanced or metastatic urothelial cancer (EV-302): patient-reported outcomes from an open-label, randomised, controlled, phase 3 study恩诺单抗维多汀联合帕博利珠单抗对比化疗在先前未经治疗的局部晚期或转移性尿路上皮癌患者中的疗效（EV-302）：一项开放标签、随机对照、III期研究的患者报告结局
errlancet oncology
IF0
err2025-05-28
err0
PREAI
errShilpa Gupta; Yohann Loriot; Michiel S Van der Heijden; Jens Bedke; Begoña P Valderrama; Eiji Kikuchi; Aude Fléchon; Daniel Petrylak; Maria De Santis; Matthew D Galsky; Jae Lyun Lee; Umang Swami; Srikala S Sridhar; Ugo De Giorgi; Phoebe Wright; Vanessa Shih; Yi-Tsung Lu; Xuesong Guan; Ryan Dillon; Aditya Shetty; Blanca Homet Moreno; Jennifer L Beaumont; Intan Purnajo; Shauna McManus; Thomas Powles
err分享
err收藏
Pembrolizumab plus enzalutamide and androgen deprivation therapy versus placebo plus enzalutamide and androgen deprivation therapy for metastatic hormone-sensitive prostate cancer: the randomized, double-blind, phase III KEYNOTE-991 study☆帕博利珠单抗联合恩扎卢胺和雄激素剥夺疗法与安慰剂联合恩扎卢胺和雄激素剥夺疗法治疗转移性激素敏感性前列腺癌：随机、双盲、III期KEYNOTE-991研究☆
errAnnals of Oncology
IF65.4
err2025-05-16
err0
PREAI
errC. Gratzke; M. Özgüroğlu; A. Peer; M.A.N. Sendur; M. Retz; J.C. Goh; W. Loidl; G. Jayram; S.-S. Byun; C. Kwak; M. Kwiatkowski; R. Manneh Kopp; J.C.V. Limón; J.F.E. Penagos; U. De Giorgi; K.M. da Trindade; C. Niu; Y. Liu; C.H. Poehlein; J.M. Piulats
err分享
err收藏
Real-World 5-Year Outcomes of Patients Treated With the Adjuvant Paclitaxel Trastuzumab (APT) Regimen for Stage I HER2-Positive Early Breast Cancer: A Retrospective International Study真实世界中接受辅助紫杉醇联合曲妥珠单抗（APT）方案治疗的I期HER2阳性早期乳腺癌患者的5年结果：一项国际回顾性研究
errClinical Breast Cancer
IF2.5
err2025-05-15
err0
PREAI
errSoraia Lobo-Martins; Veronique Debien; Elisa Agostinetto; Marianna Sirico; Giselle de Souza Carvalho; Flavia Jacobs; Chiara Molinelli; Renata Colombo Bonadio; Pedro Bergmann; Cristiano de Pádua Souza; Laura Testa; Marina Nishimuni; André João Rossi; Gabriel Kamei Guimarães; Michel Moreau; Ugo De Giorgi; José Bines; Armando Santoro; Donatienne Taylor; Francois P. Duhoux; Giacomo Barchiesi; Matteo Lambertini; Martine Piccart; Evandro de Azambuja
err分享
err收藏
Pembrolizumab plus Lenvatinib in patients with metastatic Renal Cell Carcinoma: real-world evidences from the international ARON-1 study帕博利珠单抗联合仑伐替尼在转移性肾细胞癌患者中的应用：国际ARON-1研究的真实世界证据
errCANCER IMMUNOLOGY IMMUNOTHERAPY
IF5.1
err2025-05-09
err0
errOAAI
errPorta, Camillo; Massari, Francesco; Taha, Tarek; Grande, Enrique; Bourlon, Maria T.; Kanesvaran, Ravindran; Basso, Umberto; Molina-Cerrillo, Javier; Alonso-Gordoa, Teresa; Myint, Zin W.; Fornarini, Giuseppe; Buttner, Thomas; Park, Se Hoon; Urun, Yueksel; De Giorgi, Ugo; Pichler, Renate; Rescigno, Pasquale; Buchler, Tomas; Studentova, Hana; Melichar, Bohuslav; Ansari, Jawaher; Mollica, Veronica; Kucharz, Jakub; Rizzo, Mimma; Rizzo, Alessandro; Kopp, Ray Manneh; Buti, Sebastiano; Monteiro, Fernando Sabino Marques; Soares, Andrey; Bamias, Aristotelis; Santoni, Matteo
err分享
err收藏
Exploring the promoter regions of cancer predisposition genes in patients with triple-negative breast cancer reveals the presence of rare germline variants探索三阴性乳腺癌患者中癌症易感基因的启动子区域，发现存在罕见的胚系变异。
errONCOLOGIST
IF4.2
err2025-05-08
err0
errOAAI
errPalleschi, Michela; Virga, Alessandra; Scarpi, Emanuela; Fonzi, Eugenio; Musolino, Antonino; Merloni, Filippo; Sarti, Samanta; Danesi, Rita; Ravegnani, Mila; Casadei, Chiara; Sirico, Marianna; Gianni, Caterina; Maltoni, Roberta; Bravaccini, Sara; Calistri, Daniele; Arcangeli, Valentina; Zampiga, Valentina; Cangini, Ilaria; Bandini, Erika; Mannozzi, Francesca; Falcini, Fabio; Martinelli, Giovanni; De Giorgi, Ugo; Ulivi, Paola; Tedaldi, Gianluca
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
D
David Cella
H 指数: 184 · 论文数: 1.9K
T
Toni K. Choueiri
H 指数: 149 · 论文数: 2.4K
R
Robert J. Motzer
H 指数: 148 · 论文数: 1.6K
M
Masatoshi Kudo
H 指数: 143 · 论文数: 2.8K
P
Peter R. Galle
H 指数: 128 · 论文数: 2.4K
查看更多